Table 2.

Number of Cellular Therapy Transplants for Novel Cellular Therapies in Europe 2009 Sorted by Cell Processing Mode

	Cell processing
Indications	Nonexpanded	Expanded	Untransduced	Transduced	Unsorted	Sorted
Cardiovascular
Peripheral artery disease	42	14	56		50	6
Cardiomyopathy	11	1	12		12
Heart failure	21	12	33		17	16
Myocardial ischemia	109	2	104	7	102	9
Bypass graft	14	2	16		4	12
Valve replacement
Ulcer		150	150		150
Other	23		23		23
Musculoskeletal
Bone repair (maxillofacial)	1	1	2		2
Bone repair (orthopedics)	57	11	67	1	67	1
Osteogenesis imperfecta	1		1			1
Cartilage repair	6	85	91		91
Muscle repair
Tendon/ligament	5		5		5
Reconstructive surgery	1		1		1
Other		17	17		17
Neurological
Parkinson's
Peripheral nerve regeneration
Other	5	11	13	3	5	11
Epithelial
Skin reconstruction		51	51		51
Cornea repair	24	3	27		27
Organ failure	10		10			10
Diabetes
Liver insufficiency		2		2	2
Other
Autoimmune
Neurological		80	80		80
Rheumatological		2	2		2
Gastrointestinal		5	5		5
Other		16	16		16
Graft vs. host disease		19	19		19
Total	330	484	801	13	748	66

Data only from extended questionnaire.